Amicus Therapeutics Stock Price

0.125 (0.74%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Amicus Therapeutics Inc FOLD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.125 0.74% 16.975 18:00:11
Close Price Low Price High Price Open Price Previous Close
16.975 16.76 17.17 17.00 16.85
Bid Price Ask Price Spread News
16.50 17.78 1.28 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
11,982 1,540,894 $ 17.00 $ 26,193,924 2,095,858 6.25 - 17.67
Last Trade Time Type Quantity Stock Price Currency
17:20:24 5 $ 16.95 USD

Amicus Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 4.39B 258.79M 257.21M $ 182.24M $ - -1.51 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Amicus Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical FOLD Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week15.6117.6715.4116.802,712,6961.378.74%
1 Month13.4717.6712.7815.161,910,8313.5126.02%
3 Months15.1317.6712.77514.631,727,3841.8512.19%
6 Months11.4317.6710.4813.722,193,9735.5548.51%
1 Year8.1817.676.2511.362,535,2638.80107.52%
3 Years14.4717.676.2512.272,543,7422.5117.31%
5 Years6.8117.674.4110.782,587,09910.17149.27%

Amicus Therapeutics Description

Amicus Therapeutics Inc is a biotechnology company. It is focused on discovering, developing, and delivering novel high-quality medicines for people living with rare metabolic diseases. Amicus Therapeutics is expanding a pipeline of medicines for rare metabolic diseases, including an industry- leading rare disease gene therapy portfolio.

Your Recent History
Amicus The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.